[HTML] springer.comFull View

[HTML][HTML] Medical costs of oral anticoagulants vs warfarin for atrial fibrillation patients with different stroke risks

S Deitelzweig, A Amin, Y Jing, D Makenbaeva… - Cardiology and …, 2013 - Springer
Abstract Introduction The Apixaban for the Reduction in Stroke and Other Thromboembolic
Events in Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long-term …
被引用次数：14 相关文章

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks

S Deitelzweig, A Amin, Y Jing… - Cardiology and …, 2013 - search.proquest.com
Abstract The Apixaban for the Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long-term Anticoagulation …

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks

S Deitelzweig, A Amin, Y Jing, D Makenbaeva… - Cardiology and …, 2013 - infona.pl
Introduction The Apixaban for the Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long-term Anticoagulation …

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks.

S Deitelzweig, A Amin, Y Jing… - Cardiology & …, 2013 - search.ebscohost.com
Abstract Introduction: The Apixaban for the Reduction in Stroke and Other Thromboembolic
Events in Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long-term …

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks.

S Deitelzweig, A Amin, Y Jing… - Cardiology and …, 2013 - escholarship.org
IntroductionThe Apixaban for the Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long-term Anticoagulation …
[PDF] researchgate.net

[PDF][PDF] Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks

S Deitelzweig, A Amin, Y Jing, D Makenbaeva… - 2013 - researchgate.net
ABSTRACT Introduction: The Apixaban for the Reduction in Stroke and Other
Thromboembolic Events in Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long …

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks

S Deitelzweig, A Amin, Y Jing… - Cardiology and …, 2013 - pubmed.ncbi.nlm.nih.gov
Introduction The Apixaban for the Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long-term Anticoagulation …
[PDF] academia.edu

[PDF][PDF] Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks

S Deitelzweig, A Amin, Y Jing, D Makenbaeva… - 2013 - academia.edu
ABSTRACT Introduction: The Apixaban for the Reduction in Stroke and Other
Thromboembolic Events in Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long …
[PDF] cyberleninka.org

[PDF][PDF] Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks

S Deitelzweig, A Amin, Y Jing, D Makenbaeva… - 2013 - cyberleninka.org
ABSTRACT Introduction: The Apixaban for the Reduction in Stroke and Other
Thromboembolic Events in Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long …

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks.

S Deitelzweig, A Amin, Y Jing… - Cardiology and …, 2013 - europepmc.org
Methods Rates for primary and secondary efficacy and safety outcomes (ie, clinical events)
among NVAF patients with CHADS2= 2 and≥ 3 were determined from the three OAC trials …